Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Overview of attention for article published in Breast Cancer Research, March 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 2 news outlets

Readers on

mendeley: 81 Mendeley

So far, Altmetric has seen 2 news stories from 2 outlets.

Bisphosphonates turn 50

Pediatric News , 08 Nov 2019

ORLANDO – Cumulative evidence over the years has shown that bisphosphonates reduce distant metastases in postmenopausal women…

Context May Affect Benefit of Adjuvant Clodronate in Breast Cancer

The ASCO Post, 16 Dec 2013

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.